{"title": "Monoclonal antibodies for malaria prevention. Preferred product characteristics and clinical development considerations.WHO 20 April 2023", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2023-05-08", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "[Monoclonal antibodies for malaria prevention. Preferred product characteristics and clinical development considerations.WHO 20 April 2023](https://apps.who.int/iris/rest/bitstreams/1498084/retrieve)\nDocumento t\u00e9cnico publicado por la\n[Organizaci\u00f3n Mundial de la Salud](https://www.who.int/) sobre prevenci\u00f3n de la malaria por anticuerpos monoclonales.\nLas caracter\u00edsticas preferidas del producto (PPC) son herramientas clave para incentivar y guiar el desarrollo de productos de salud que se necesitan con urgencia. Los PPC publicados aqu\u00ed tienen como objetivo articular la necesidad de salud p\u00fablica, las caracter\u00edsticas preferidas y las consideraciones de desarrollo cl\u00ednico para los anticuerpos monoclonales (mAbs) para la prevenci\u00f3n de la malaria. Junto con el desarrollo de nuevas vacunas contra la malaria y medicamentos de quimioprevenci\u00f3n, ha habido avances recientes en investigaci\u00f3n y desarrollo en el desarrollo de mAbs para la prevenci\u00f3n de la malaria. La inmunizaci\u00f3n pasiva con mAbs mediante la administraci\u00f3n directa de anticuerpos funcionales podr\u00eda superar algunas de las limitaciones de las vacunas al proporcionar protecci\u00f3n inmediata.\nAdem\u00e1s, los mAbs con reg\u00edmenes de dosis simplificados podr\u00edan eludir algunos de los problemas de cobertura y adherencia que enfrenta la quimioprevenci\u00f3n de la malaria. Para apoyar esta \u00e1rea de investigaci\u00f3n y desarrollo en r\u00e1pido desarrollo, la OMS convoc\u00f3 a un grupo de desarrollo cient\u00edfico para considerar los PPC para mAbs que se utilizar\u00e1n para la prevenci\u00f3n de la malaria, con un enfoque en la reducci\u00f3n de la morbilidad y mortalidad en lactantes y ni\u00f1os debido a Plasmodium falciparum. Idioma: ingl\u00e9s", "language": null, "image": null, "pagetype": null, "links": ["http://www.sld.cu", "http://blogs.sld.cu", "http://blogs.sld.cu/marionod/", "http://blogs.sld.cu/marionod/contacto", "http://blogs.sld.cu/marionod/mapa-de-sitio/", "https://blogs.sld.cu/marionod/", "http://blogs.sld.cu/marionod/", "http://blogs.sld.cu/marionod/acerca-de-este-blog/", "http://blogs.sld.cu/marionod/politica-del-proxy-infomed/", "http://blogs.sld.cu/marionod/recomendacion/", "https://blogs.sld.cu/marionod/2023/05/08/monoclonal-antibodies-for-malaria-prevention-preferred-product-characteristics-and-clinical-development-considerations-who-20-april-2023/", "https://blogs.sld.cu/marionod/2023/05/08/monoclonal-antibodies-for-malaria-prevention-preferred-product-characteristics-and-clinical-development-considerations-who-20-april-2023/#respond", "https://apps.who.int/iris/rest/bitstreams/1498084/retrieve", "https://www.who.int/", "https://blogs.sld.cu/marionod/category/anticuerpos-monoclonales/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/malaria/", "https://blogs.sld.cu/marionod/category/organizacion-mundial-de-la-salud/", "https://blogs.sld.cu/marionod/category/prevencion/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2023/05/", "https://blogs.sld.cu/marionod/2023/05/08/monoclonal-antibodies-for-malaria-prevention-preferred-product-characteristics-and-clinical-development-considerations-who-20-april-2023/#respond", "https://blogs.sld.cu/marionod/2023/05/08/monoclonal-antibodies-for-malaria-prevention-preferred-product-characteristics-and-clinical-development-considerations-who-20-april-2023/", "https://blogs.sld.cu/marionod/2023/04/21/expert-review-of-vaccines/", "https://blogs.sld.cu/marionod/2023/04/21/expert-review-of-vaccines/#respond", "https://www.tandfonline.com/journals/ierv20", "https://blogs.sld.cu/marionod/category/inmunologia/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/revistas/", "https://blogs.sld.cu/marionod/category/vacunas/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2023/04/", "https://blogs.sld.cu/marionod/2023/04/21/expert-review-of-vaccines/#respond", "https://blogs.sld.cu/marionod/2023/04/21/expert-review-of-vaccines/", "https://blogs.sld.cu/marionod/2022/07/18/human-vaccines-immunotherapeutics/", "https://blogs.sld.cu/marionod/2022/07/18/human-vaccines-immunotherapeutics/#respond", "https://www.tandfonline.com/journals/khvi20", "https://www.isv-online.org/", "https://blogs.sld.cu/marionod/category/inmunologia/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/revistas/", "https://blogs.sld.cu/marionod/category/sociedades/", "https://blogs.sld.cu/marionod/category/vacunas/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2022/07/", "https://blogs.sld.cu/marionod/2022/07/18/human-vaccines-immunotherapeutics/#respond", "https://blogs.sld.cu/marionod/2022/07/18/human-vaccines-immunotherapeutics/", "https://blogs.sld.cu/marionod/2021/07/23/current-trends-in-vaccines-and-vaccinology/", "https://blogs.sld.cu/marionod/2021/07/23/current-trends-in-vaccines-and-vaccinology/#respond", "https://www.boffinaccess.com/journals/currents-trends-in-vaccines-vaccinology/ctvv", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/revistas/", "https://blogs.sld.cu/marionod/category/vacunas/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2021/07/", "https://blogs.sld.cu/marionod/2021/07/23/current-trends-in-vaccines-and-vaccinology/#respond", "https://blogs.sld.cu/marionod/2021/07/23/current-trends-in-vaccines-and-vaccinology/", "https://blogs.sld.cu/marionod/2021/02/11/society-for-immunotherapy-of-cancer-consensus-statement-on-immunotherapy-for-the-treatment-of-bladder-carcinoma/", "https://blogs.sld.cu/marionod/2021/02/11/society-for-immunotherapy-of-cancer-consensus-statement-on-immunotherapy-for-the-treatment-of-bladder-carcinoma/#respond", "https://jitc.bmj.com/content/5/1/68", "https://jitc.bmj.com/", "https://www.sitcancer.org/", "https://blogs.sld.cu/marionod/category/articulos/", "https://blogs.sld.cu/marionod/category/cancer/", "https://blogs.sld.cu/marionod/category/consensos/", "https://blogs.sld.cu/marionod/category/declaracion/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/sociedades/", "https://blogs.sld.cu/marionod/category/tratamiento/", "https://blogs.sld.cu/marionod/category/urologia/", "https://blogs.sld.cu/marionod/category/vejiga/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2021/02/", "https://blogs.sld.cu/marionod/2021/02/11/society-for-immunotherapy-of-cancer-consensus-statement-on-immunotherapy-for-the-treatment-of-bladder-carcinoma/#respond", "https://blogs.sld.cu/marionod/2021/02/11/society-for-immunotherapy-of-cancer-consensus-statement-on-immunotherapy-for-the-treatment-of-bladder-carcinoma/", "https://blogs.sld.cu/marionod/2021/01/07/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immunotherapy-for-the-treatment-of-lymphoma/", "https://blogs.sld.cu/marionod/2021/01/07/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immunotherapy-for-the-treatment-of-lymphoma/#respond", "https://jitc.bmj.com/content/8/2/e001235", "http://www.sitcancer.org/home", "https://blogs.sld.cu/marionod/category/articulos/", "https://blogs.sld.cu/marionod/category/cancer/", "https://blogs.sld.cu/marionod/category/guias-de-practica-clinica/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/linfoma-de-hodgkin/", "https://blogs.sld.cu/marionod/category/linfomas/", "https://blogs.sld.cu/marionod/category/sociedades/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2021/01/", "https://blogs.sld.cu/marionod/2021/01/07/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immunotherapy-for-the-treatment-of-lymphoma/#respond", "https://blogs.sld.cu/marionod/2021/01/07/society-for-immunotherapy-of-cancer-sitc-clinical-practice-guideline-on-immunotherapy-for-the-treatment-of-lymphoma/", "https://blogs.sld.cu/marionod/2020/07/31/vaccine-research/", "https://blogs.sld.cu/marionod/2020/07/31/vaccine-research/#respond", "http://vacres.pasteur.ac.ir/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/revistas/", "https://blogs.sld.cu/marionod/category/vacunas/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2020/07/", "https://blogs.sld.cu/marionod/2020/07/31/vaccine-research/#respond", "https://blogs.sld.cu/marionod/2020/07/31/vaccine-research/", "https://blogs.sld.cu/marionod/2020/05/14/oncoimmunology/", "https://blogs.sld.cu/marionod/2020/05/14/oncoimmunology/#respond", "https://www.tandfonline.com/toc/koni20/current", "https://blogs.sld.cu/marionod/category/cancer/", "https://blogs.sld.cu/marionod/category/inmunologia/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/revistas/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2020/05/", "https://blogs.sld.cu/marionod/2020/05/14/oncoimmunology/#respond", "https://blogs.sld.cu/marionod/2020/05/14/oncoimmunology/", "https://blogs.sld.cu/marionod/2019/09/17/therapeutic-advances-in-vaccines-and-immunotherapy/", "https://blogs.sld.cu/marionod/2019/09/17/therapeutic-advances-in-vaccines-and-immunotherapy/#respond", "https://journals.sagepub.com/home/tav", "https://blogs.sld.cu/marionod/category/inmunologia/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/prevencion/", "https://blogs.sld.cu/marionod/category/revistas/", "https://blogs.sld.cu/marionod/category/vacunas/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2019/09/", "https://blogs.sld.cu/marionod/2019/09/17/therapeutic-advances-in-vaccines-and-immunotherapy/#respond", "https://blogs.sld.cu/marionod/2019/09/17/therapeutic-advances-in-vaccines-and-immunotherapy/", "https://blogs.sld.cu/marionod/2018/06/06/society-for-immunotherapy-of-cancer-sitc-cancer-immunotherapy-guidelines/", "https://blogs.sld.cu/marionod/2018/06/06/society-for-immunotherapy-of-cancer-sitc-cancer-immunotherapy-guidelines/#respond", "http://www.sitcancer.org/research/cancer-immunotherapy-guidelines", "http://www.sitcancer.org/", "https://jitc.biomedcentral.com/articles/sections/guidelines-and-consensus-statements", "https://blogs.sld.cu/marionod/category/cancer/", "https://blogs.sld.cu/marionod/category/consensos/", "https://blogs.sld.cu/marionod/category/declaracion/", "https://blogs.sld.cu/marionod/category/guias-de-practica-clinica/", "https://blogs.sld.cu/marionod/category/inmunoterapia/", "https://blogs.sld.cu/marionod/category/sociedades/", "https://blogs.sld.cu/marionod/author/marionod/", "https://blogs.sld.cu/marionod/2018/06/", "https://blogs.sld.cu/marionod/2018/06/06/society-for-immunotherapy-of-cancer-sitc-cancer-immunotherapy-guidelines/#respond", "https://blogs.sld.cu/marionod/2018/06/06/society-for-immunotherapy-of-cancer-sitc-cancer-immunotherapy-guidelines/", "https://blogs.sld.cu/marionod/category/inmunoterapia/page/2/", "https://blogs.sld.cu/marionod/category/inmunoterapia/page/3/", "https://blogs.sld.cu/marionod/category/inmunoterapia/page/4/", "https://blogs.sld.cu/marionod/category/inmunoterapia/page/5/", "https://blogs.sld.cu/marionod/category/inmunoterapia/page/6/", "https://blogs.sld.cu/marionod/category/inmunoterapia/page/7/", "https://blogs.sld.cu/marionod/category/inmunoterapia/page/2/", "http://blogs.sld.cu/marionod/acerca-de-este-blog/", "http://blogs.sld.cu/marionod/politica-del-proxy-infomed/", "http://blogs.sld.cu/marionod/recomendacion/", "https://blogs.sld.cu/marionod/2023/09/19/jmir-bioinformatics-and-biotechnology/", "https://blogs.sld.cu/marionod/2023/09/19/pediatric-infectious-disease/", "https://blogs.sld.cu/marionod/2023/09/18/rwanda-journal-of-medicine-and-health-sciences/", "https://blogs.sld.cu/marionod/2023/09/18/journal-of-molecular-and-cellular-cardiology-plus/", "https://blogs.sld.cu/marionod/2023/09/08/smart-molecules/", "https://blogs.sld.cu/marionod/wp-login.php", "https://blogs.sld.cu/marionod/feed/", "https://blogs.sld.cu/marionod/comments/feed/", "https://es.wordpress.org/", "http://www.sld.cu/temas.php?idv=11649", "http://blogs.sld.cu/marionod/contacto", "http://www.sld.cu/", "http://www.semiologic.com/software/sem-reloaded/", "http://skins.semiologic.com/copywriter/", "http://www.mesoconcepts.com"]}